The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I trial of a dual TOR kinase and DNA-PK inhibitor (CC-115) in advanced solid and hematologic cancers.
 
Pamela N. Munster
Stock and Other Ownership Interests - OncoSec (I)
Honoraria - Amgen (I); Prometheus (I); Threshold Pharmaceuticals
Consulting or Advisory Role - HUYA Bioscience International
Research Funding - Andes Biotechnologies (Inst); Biomarin (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Immune Design (Inst); Intellikine (Inst); Merck (Inst); Merrimack (Inst); Nektar (Inst); Novartis (Inst); OncoMed (Inst); Onconova Therapeutics (Inst); oncosec (Inst); Pfizer (Inst); Piramal Life Science (Inst); Plexxikon (Inst); Sanofi (Inst)
 
Amit Mahipal
No Relationships to Disclose
 
John J. Nemunaitis
Employment - Gradalis
Leadership - Gradalis
Stock and Other Ownership Interests - Gradalis
Honoraria - Amgen
Consulting or Advisory Role - Amgen
Speakers' Bureau - Amgen (I)
Patents, Royalties, Other Intellectual Property - Gradalis
Travel, Accommodations, Expenses - Amgen; Baxalta; Takeda
 
Monica M. Mita
No Relationships to Disclose
 
Luis G. Paz-Ares
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Lilly; MSD; Pfizer; Roche/Genentech
 
Christophe Massard
No Relationships to Disclose
 
Tom Mikkelsen
Honoraria - Roche/Genentech
Consulting or Advisory Role - Orbus Therapeutics; Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Cristina Cruz
No Relationships to Disclose
 
Dana E. Rathkopf
Consulting or Advisory Role - Janssen Oncology
Research Funding - Celgene (Inst); Ferring (Inst); Janssen Oncology (Inst); Medivation (Inst); Millennium (Inst); Novartis (Inst); Takeda (Inst)
 
George R. Blumenschein
No Relationships to Disclose
 
Manuel Hidalgo
No Relationships to Disclose
 
David C. Smith
Research Funding - Agensys (Inst); Aragon Pharmaceuticals (Inst); Atterocor (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb/Medarex (Inst); Celgene (Inst); Eisai (Inst); Exelixis (Inst); ImClone Systems (Inst); Incyte (Inst); Lilly (Inst); MedImmune (Inst); Millennium (Inst); Novartis (Inst); Oncogenex (Inst); OncoMed (Inst); PSMA Development Company (Inst); Puma Biotechnology (Inst); Regeneron (Inst); Seagen (Inst); Tekmira (Inst); Teva (Inst)
 
Barbara Eichhorst
Consulting or Advisory Role - Gilead Sciences; GlaxoSmithKline; Janssen-Cilag; Mundipharma
Speakers' Bureau - Celgene; Gilead Sciences; GlaxoSmithKline; Janssen-Cilag; Mundipharma; Roche/Genentech
Research Funding - Mundipharma; Roche
Travel, Accommodations, Expenses - GlaxoSmithKline; Mundipharma; Roche
 
Timothy Francis Cloughesy
Consulting or Advisory Role - Abbvie; Agios; Amgen; Celgene; Celldex; cortice; CytRx Corporation; Lpath; Nektar; NewGen Therapeutics; Novartis; Novocure; Oxigene; proximagen; Roche/Genentech; Stemcycle; Tocagen; Upsher-Smith; VBL Therapeutics; wellcome trust
 
Brett Garrick
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Torsten Trowe
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Ellen Filvaroff
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Kristen Hege
Employment - Celgene
Stock and Other Ownership Interests - Celgene
Patents, Royalties, Other Intellectual Property - Celgene
 
Johanna C. Bendell
No Relationships to Disclose